Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Sblendorio Glenn, Director. Insider active across 5 companies, notably Intercept Pharmaceuticals, INC.. In total, 32 disclosures have been recorded. Breakdown: 0 buy · 3 sells. Total volume traded: €2m. History available since 27 May 2021. The latest transaction was filed on 27 April 2026 (Disposition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Sblendorio Glenn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
22,163 shares@ US$1.451.3% of flowCommon StockSEC:0001104659-21-153685:0
25 of 32 declarations
About Sblendorio Glenn
SBLENDORIO GLENN is Chief Executive Officer and Director. He has 32 filings in total, and in the sampled recent filings the reported volume is 0 in buys and 3782427 in sells, with transactions ranging from 2016-01-04 to 2026-04-27.